Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat

Although the pharmacological effects of fibroblast growth factor 21 (FGF21) are well-documented, uncertainty about its role in regulating excessive energy intake remains. Here, we show that FGF21 improves systemic insulin sensitivity by promoting the healthy expansion of subcutaneous adipose tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huating, Wu, Guangyu, Fang, Qichen, Zhang, Mingliang, Hui, Xiaoyan, Sheng, Bin, Wu, Liang, Bao, Yuqian, Li, Peng, Xu, Aimin, Jia, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773530/
https://www.ncbi.nlm.nih.gov/pubmed/29348470
http://dx.doi.org/10.1038/s41467-017-02677-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773530/
https://www.ncbi.nlm.nih.gov/pubmed/29348470
http://dx.doi.org/10.1038/s41467-017-02677-9

Ejemplares similares